{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:00:39Z","timestamp":1790870439461,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyloid transthyretin-derived (ATTR) amyloidosis is a degenerative, systemic disease characterized by transthyretin fibril deposition in organs like the heart, kidneys, liver, and skin. In this study, we report the cryo-EM structure of transthyretin fibrils isolated from skin tissue of a living patient carrying a rare genetic mutation (ATTRv F64S). The structure adopts a highly conserved fold previously observed in other ATTR fibrils from various tissues or different genetic variants. Mass spectrometry was used to evaluate fibril content and to identify common post-translational modifications. The structural consistency between ATTR filaments from different tissues or patients validates non-invasive skin biopsy as a diagnostic tool.<\/jats:p>","DOI":"10.1038\/s41467-025-67457-2","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T04:06:13Z","timestamp":1765857973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Structure of ATTRv-F64S fibrils isolated from skin tissue of a living patient"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5642-3991","authenticated-orcid":false,"given":"Jun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5222-7042","authenticated-orcid":false,"given":"Xuefeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8419-277X","authenticated-orcid":false,"given":"Elena","family":"Vacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4063-4502","authenticated-orcid":false,"given":"Andrea","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8105-9671","authenticated-orcid":false,"given":"Matteo","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-4620","authenticated-orcid":false,"given":"Giorgia","family":"Melli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1218-6714","authenticated-orcid":false,"given":"Andreas","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"67457_CR1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/10408363.2024.2350379","volume":"61","author":"ZL Almeida","year":"2024","unstructured":"Almeida, Z. L., Vaz, D. C. & Brito, R. M. M. Transthyretin mutagenesis: impact on amyloidogenesis and disease. Crit. Rev. Cl. Lab Sci. 61, 616\u2013640 (2024).","journal-title":"Crit. Rev. Cl. Lab Sci."},{"key":"67457_CR2","doi-asserted-by":"publisher","first-page":"592644","DOI":"10.3389\/fnmol.2020.592644","volume":"13","author":"F Bezerra","year":"2020","unstructured":"Bezerra, F., Saraiva, M. J. & Almeida, M. R. Modulation of the mechanisms driving transthyretin amyloidosis. Front. Mol. Neurosci. 13, 592644 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"67457_CR3","doi-asserted-by":"publisher","first-page":"E2403","DOI":"10.1002\/humu.22619","volume":"35","author":"DM Rowczenio","year":"2014","unstructured":"Rowczenio, D. M. et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum. Mutat. 35, E2403\u2013E2412 (2014).","journal-title":"Hum. Mutat."},{"key":"67457_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","volume":"8","author":"Y Ando","year":"2013","unstructured":"Ando, Y. et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J. Rare Dis. 8, 31 (2013).","journal-title":"Orphanet J. Rare Dis."},{"key":"67457_CR5","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg, F. L. & Berk, J. L. Transthyretin (TTR) cardiac amyloidosis. Circulation 126, 1286\u20131300 (2012).","journal-title":"Circulation"},{"key":"67457_CR6","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","volume":"36","author":"E Gonz\u00e1lez-L\u00f3pez","year":"2015","unstructured":"Gonz\u00e1lez-L\u00f3pez, E. et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur. Heart J. 36, 2585\u20132594 (2015).","journal-title":"Eur. Heart J."},{"key":"67457_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/path.1759","volume":"206","author":"J Bergstrom","year":"2005","unstructured":"Bergstrom, J. et al. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J. Pathol. 206, 224\u2013232 (2005).","journal-title":"J. Pathol."},{"key":"67457_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/13506129.2013.797890","volume":"20","author":"E Ihse","year":"2013","unstructured":"Ihse, E. et al. Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Amyloid 20, 142\u2013150 (2013).","journal-title":"Amyloid"},{"key":"67457_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Structures of alpha-synuclein filaments from human brains with Lewy pathology. Nature 610, 791\u2013795 (2022).","journal-title":"Nature"},{"key":"67457_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbpa.2021.05.007","volume":"64","author":"SP Moon","year":"2021","unstructured":"Moon, S. P., Balana, A. T. & Pratt, M. R. Consequences of post-translational modifications on amyloid proteins as revealed by protein semisynthesis. Curr. Opin. Chem. Biol. 64, 76\u201389 (2021).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"67457_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00401-016-1546-0","volume":"131","author":"S Kumar","year":"2016","unstructured":"Kumar, S. et al. Phosphorylation of the amyloid beta-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity. Acta Neuropathol. 131, 525\u2013537 (2016).","journal-title":"Acta Neuropathol."},{"key":"67457_CR12","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1002\/anie.201611750","volume":"56","author":"A Chiki","year":"2017","unstructured":"Chiki, A. et al. Mutant Exon1 huntingtin aggregation is regulated by T3 phosphorylation-induced structural changes and crosstalk between T3 phosphorylation and acetylation at K6. Angew. Chem. Int. Ed. Engl. 56, 5202\u20135207 (2017).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"67457_CR13","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1021\/ja300094r","volume":"134","author":"F Meier","year":"2012","unstructured":"Meier, F. et al. Semisynthetic, site-specific ubiquitin modification of alpha-synuclein reveals differential effects on aggregation. J. Am. Chem. Soc. 134, 5468\u20135471 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"67457_CR14","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","volume":"10","author":"M Schmidt","year":"2019","unstructured":"Schmidt, M. et al. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Nat. Commun. 10, 5008 (2019).","journal-title":"Nat. Commun."},{"key":"67457_CR15","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1038\/s41467-021-27481-4","volume":"12","author":"I Iakovleva","year":"2021","unstructured":"Iakovleva, I. et al. Structural basis for transthyretin amyloid formation in vitreous body of the eye. Nat. Commun. 12, 7141 (2021).","journal-title":"Nat. Commun."},{"key":"67457_CR16","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1038\/s41467-022-33591-4","volume":"13","author":"M Steinebrei","year":"2022","unstructured":"Steinebrei, M. et al. Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis. Nat. Commun. 13, 6398 (2022).","journal-title":"Nat. Commun."},{"key":"67457_CR17","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.1038\/s41467-023-43301-3","volume":"14","author":"M Steinebrei","year":"2023","unstructured":"Steinebrei, M. et al. Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis. Nat. Commun. 14, 7623 (2023).","journal-title":"Nat. Commun."},{"key":"67457_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s42003-024-06588-6","volume":"7","author":"BA Nguyen","year":"2024","unstructured":"Nguyen, B. A. et al. Cryo-EM confirms a common fibril fold in the heart of four patients with ATTRwt amyloidosis. Commun. Biol. 7, 905 (2024).","journal-title":"Commun. Biol."},{"key":"67457_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41467-024-44820-3","volume":"15","author":"BA Nguyen","year":"2024","unstructured":"Nguyen, B. A. et al. Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy. Nat. Commun. 15, 581 (2024).","journal-title":"Nat. Commun."},{"key":"67457_CR20","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.str.2024.09.021","volume":"32","author":"BA Nguyen","year":"2024","unstructured":"Nguyen, B. A. et al. ATTRv-V30M amyloid fibrils from heart and nerves exhibit structural homogeneity. Structure 32, 2244\u20132250 (2024).","journal-title":"Structure"},{"key":"67457_CR21","doi-asserted-by":"publisher","unstructured":"Fernandez-Ramirez, M. D. C. et al. Multi-organ structural homogeneity of amyloid fibrils in ATTRv-T60A amyloidosis patients, revealed by Cryo-EM. bioRxiv https:\/\/doi.org\/10.1101\/2024.05.14.594218 (2024).","DOI":"10.1101\/2024.05.14.594218"},{"key":"67457_CR22","doi-asserted-by":"publisher","unstructured":"Ahmed, Y. et al. Amyloid fibril polymorphism in the heart of an ATTR amyloidosis patient with polyneuropathy attributed to the V122Delta variant. bioRxiv https:\/\/doi.org\/10.1101\/2024.05.09.593396 (2024).","DOI":"10.1101\/2024.05.09.593396"},{"key":"67457_CR23","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1002\/acn3.51924","volume":"10","author":"S Pinton","year":"2023","unstructured":"Pinton, S. et al. Amyloid detection and typing yield of skin biopsy in systemic amyloidosis and polyneuropathy. Ann. Clin. Transl. Neurol. 10, 2347\u20132359 (2023).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"67457_CR24","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.1002\/anie.201511524","volume":"55","author":"K Annamalai","year":"2016","unstructured":"Annamalai, K. et al. Polymorphism of amyloid fibrils in vivo. Angew. Chem. Int Ed. Engl. 55, 4822\u20134825 (2016).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"67457_CR25","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512\u2013D520 (2015).","journal-title":"Nucleic Acids Res."},{"key":"67457_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cell.2018.04.033","volume":"174","author":"BT Weinert","year":"2018","unstructured":"Weinert, B. T. et al. Time-resolved analysis reveals rapid dynamics and broad scope of the CBP\/p300 acetylome. Cell 174, 231\u2013244 (2018).","journal-title":"Cell"},{"key":"67457_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41587-019-0344-3","volume":"38","author":"D Ochoa","year":"2020","unstructured":"Ochoa, D. et al. The functional landscape of the human phosphoproteome. Nat. Biotechnol. 38, 365\u2013373 (2020).","journal-title":"Nat. Biotechnol."},{"key":"67457_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1039\/D2FD00034B","volume":"240","author":"S Lovestam","year":"2022","unstructured":"Lovestam, S. & Scheres, S. H. W. High-throughput cryo-EM structure determination of amyloids. Faraday Discuss. 240, 243\u2013260 (2022).","journal-title":"Faraday Discuss."},{"key":"67457_CR29","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1042\/BCJ20210708","volume":"478","author":"D Kimanius","year":"2021","unstructured":"Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169\u20134185 (2021).","journal-title":"Biochem. J."},{"key":"67457_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/13506129.2019.1583198","volume":"26","author":"T Masuda","year":"2019","unstructured":"Masuda, T. et al. Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis. Amyloid 26, 79\u201380 (2019).","journal-title":"Amyloid"},{"key":"67457_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ncomms1255","volume":"2","author":"TJ Cohen","year":"2011","unstructured":"Cohen, T. J. et al. The acetylation of Tau inhibits its function and promotes pathological Tau aggregation. Nat. Commun. 2, 252 (2011).","journal-title":"Nat. Commun."},{"key":"67457_CR32","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1038\/s41467-023-41672-1","volume":"14","author":"P Chakraborty","year":"2023","unstructured":"Chakraborty, P. et al. Acetylation discriminates disease-specific Tau deposition. Nat. Commun. 14, 5919 (2023).","journal-title":"Nat. Commun."},{"key":"67457_CR33","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.str.2023.05.020","volume":"31","author":"L Li","year":"2023","unstructured":"Li, L. et al. Disease-associated patterns of acetylation stabilize Tau fibril formation. Structure 31, 1025\u20131037 (2023).","journal-title":"Structure"},{"key":"67457_CR34","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1021\/jacs.8b02668","volume":"140","author":"M Haj-Yahya","year":"2018","unstructured":"Haj-Yahya, M. & Lashuel, H. A. Protein semisynthesis provides access to Tau disease-associated post-translational modifications (PTMs) and paves the way to deciphering the Tau PTM code in health and diseased states. J. Am. Chem. Soc. 140, 6611\u20136621 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"67457_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","volume":"67","author":"SW Min","year":"2010","unstructured":"Min, S. W. et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67, 953\u2013966 (2010).","journal-title":"Neuron"},{"key":"67457_CR36","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1038\/ncomms6845","volume":"6","author":"TJ Cohen","year":"2015","unstructured":"Cohen, T. J. et al. An acetylation switch controls TDP-43 function and aggregation propensity. Nat. Commun. 6, 5845 (2015).","journal-title":"Nat. Commun."},{"key":"67457_CR37","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41467-022-28822-7","volume":"13","author":"J Garcia Morato","year":"2022","unstructured":"Garcia Morato, J. et al. Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43. Nat. Commun. 13, 1223 (2022).","journal-title":"Nat. Commun."},{"key":"67457_CR38","doi-asserted-by":"publisher","first-page":"101363","DOI":"10.1016\/j.jbc.2021.101363","volume":"297","author":"L Gottlieb","year":"2021","unstructured":"Gottlieb, L., Guo, L., Shorter, J. & Marmorstein, R. N-alpha-acetylation of Huntingtin protein increases its propensity to aggregate. J. Biol. Chem. 297, 101363 (2021).","journal-title":"J. Biol. Chem."},{"key":"67457_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","volume":"137","author":"H Jeong","year":"2009","unstructured":"Jeong, H. et al. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137, 60\u201372 (2009).","journal-title":"Cell"},{"key":"67457_CR40","doi-asserted-by":"publisher","first-page":"e2000374","DOI":"10.1371\/journal.pbio.2000374","volume":"15","author":"RM de Oliveira","year":"2017","unstructured":"de Oliveira, R. M. et al. The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol. 15, e2000374 (2017).","journal-title":"PLoS Biol."},{"key":"67457_CR41","doi-asserted-by":"publisher","unstructured":"Shimogawa, M. et al. Investigation of all disease-relevant lysine acetylation sites in \u03b1-synuclein enabled by non-canonical amino acid mutagenesis. bioRxiv, 2025.2001.2021.634178 https:\/\/doi.org\/10.1101\/2025.01.21.634178 (2025).","DOI":"10.1101\/2025.01.21.634178"},{"key":"67457_CR42","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","volume":"109","author":"CE Bulawa","year":"2012","unstructured":"Bulawa, C. E. et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc. Natl. Acad. Sci. USA 109, 9629\u20139634 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67457_CR43","doi-asserted-by":"publisher","first-page":"28932","DOI":"10.1074\/jbc.M115.659912","volume":"290","author":"L Saelices","year":"2015","unstructured":"Saelices, L. et al. Uncovering the mechanism of aggregation of human transthyretin. J. Biol. Chem. 290, 28932\u201328943 (2015).","journal-title":"J. Biol. Chem."},{"key":"67457_CR44","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res. 33, W382\u2013W388 (2005).","journal-title":"Nucleic Acids Res."},{"key":"67457_CR45","doi-asserted-by":"publisher","first-page":"7261","DOI":"10.1038\/s41467-022-34636-4","volume":"13","author":"S Banerjee","year":"2022","unstructured":"Banerjee, S. et al. Amyloid fibril structure from the vascular variant of systemic AA amyloidosis. Nat. Commun. 13, 7261 (2022).","journal-title":"Nat. Commun."},{"key":"67457_CR46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41467-021-21126-2","volume":"12","author":"L Radamaker","year":"2021","unstructured":"Radamaker, L. et al. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis. Nat. Commun. 12, 875 (2021).","journal-title":"Nat. Commun."},{"key":"67457_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2020.01.027","volume":"180","author":"T Arakhamia","year":"2020","unstructured":"Arakhamia, T. et al. Posttranslational modifications mediate the structural diversity of tauopathy strains. Cell 180, 633\u2013644 e612 (2020).","journal-title":"Cell"},{"key":"67457_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00401-022-02403-w","volume":"143","author":"SAM Holec","year":"2022","unstructured":"Holec, S. A. M., Liu, S. L. & Woerman, A. L. Consequences of variability in alpha-synuclein fibril structure on strain biology. Acta Neuropathol. 143, 311\u2013330 (2022).","journal-title":"Acta Neuropathol."},{"key":"67457_CR49","doi-asserted-by":"publisher","first-page":"20305","DOI":"10.1073\/pnas.1922741117","volume":"117","author":"K Zhao","year":"2020","unstructured":"Zhao, K. et al. Parkinson\u2019s disease-related phosphorylation at Tyr39 rearranges \u03b1-synuclein amyloid fibril structure revealed by cryo-EM. P Natl. Acad. Sci. USA 117, 20305\u201320315 (2020).","journal-title":"P Natl. Acad. Sci. USA"},{"key":"67457_CR50","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jamaneurol.2024.4631","volume":"82","author":"D Adams","year":"2025","unstructured":"Adams, D. et al. Five-year results with patisiran for hereditary transthyretin amyloidosis with polyneuropathy: a randomized clinical trial with open-label extension. JAMA Neurol. 82, 228\u2013236 (2025).","journal-title":"JAMA Neurol."},{"key":"67457_CR51","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s40259-022-00550-w","volume":"36","author":"M Nuvolone","year":"2022","unstructured":"Nuvolone, M., Nevone, A. & Merlini, G. Targeting amyloid fibrils by passive immunotherapy in systemic amyloidosis. BioDrugs 36, 591\u2013608 (2022).","journal-title":"BioDrugs"},{"key":"67457_CR52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/ene.12842","volume":"23","author":"V Provitera","year":"2016","unstructured":"Provitera, V. et al. A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur. J. Neurol. 23, 333\u2013338 (2016).","journal-title":"Eur. J. Neurol."},{"key":"67457_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"67457_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"67457_CR55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1107\/S2059798319016577","volume":"76","author":"SHW Scheres","year":"2020","unstructured":"Scheres, S. H. W. Amyloid structure determination in RELION-3.1. Acta Crystallogr. D. Struct. Biol. 76, 94\u2013101 (2020).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"67457_CR56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"67457_CR57","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"67457_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"67457_CR59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."},{"key":"67457_CR60","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1107\/S2059798318009324","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. New tools for the analysis and validation of cryo-EM maps and atomic models. Acta Crystallogr. D. Struct. Biol. 74, 814\u2013840 (2018).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"67457_CR61","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using stagetips. Nat. Protoc. 2, 1896\u20131906 (2007).","journal-title":"Nat. Protoc."},{"key":"67457_CR62","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1074\/mcp.TIR120.002048","volume":"19","author":"F Yu","year":"2020","unstructured":"Yu, F. et al. Fast quantitative analysis of timsTOF PASEF Data with MSFragger and IonQuant. Mol. Cell Proteom. 19, 1575\u20131585 (2020).","journal-title":"Mol. Cell Proteom."},{"key":"67457_CR63","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nmeth.4256","volume":"14","author":"AT Kong","year":"2017","unstructured":"Kong, A. T., Leprevost, F. V., Avtonomov, D. M., Mellacheruvu, D. & Nesvizhskii, A. I. MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics. Nat. Methods 14, 513\u2013520 (2017).","journal-title":"Nat. Methods"},{"key":"67457_CR64","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67457-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:12:35Z","timestamp":1769213555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67457-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67457"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67457-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"781"}}